BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 33422017)

  • 1. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
    Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
    Yin S; Wu L; Zhang F; Huang X; Wu J; Wang X; Lin T
    Liver Int; 2023 Nov; 43(11):2415-2424. PubMed ID: 37592870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
    Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
    Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.
    Satterthwaite R; Ozgu I; Shidban H; Aswad S; Sunga V; Zapanta R; Asai P; Bogaard T; Khetan U; Mendez RG; Mendez R
    Transplantation; 1997 Aug; 64(3):432-5. PubMed ID: 9275109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
    Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
    Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
    Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
    Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN; Pereira BJ
    Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
    Chancharoenthana W; Townamchai N; Pongpirul K; Kittiskulnam P; Leelahavanichkul A; Avihingsanon Y; Suankratay C; Wattanatorn S; Kittikowit W; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Transplant; 2014 Dec; 14(12):2814-20. PubMed ID: 25395260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N; Tabatabaei SV; Blum HE; Alavian SM
    Transpl Infect Dis; 2012 Oct; 14(5):445-51. PubMed ID: 22970743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
    Holt D; Thomas R; Van Thiel D; Brems JJ
    Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.
    Chen GD; Gu JL; Qiu J; Chen LZ
    Transpl Infect Dis; 2013 Jun; 15(3):300-5. PubMed ID: 23473005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
    Bohorquez HE; Cohen AJ; Girgrah N; Bruce DS; Carmody IC; Joshi S; Reichman TW; Therapondos G; Mason AL; Loss GE
    Liver Transpl; 2013 Jun; 19(6):611-8. PubMed ID: 23526668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.